Can a chatbot help beat opioid addiction? new trial aims to find out
NCT ID NCT06845878
First seen Jun 25, 2026 · Last updated Jul 28, 2026 · Updated 3 times
Summary
This study tests whether an AI chatbot called Suzy can help people recovering from opioid use disorder stay engaged with their care. Over 12 weeks, 55 participants will use the chatbot to prepare for appointments, find community resources, and learn coping techniques. Researchers will measure changes in drug use severity, anxiety, depression, and self-efficacy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chatbot (Suzy)
- What this could lead to
- If it works, this could provide a low-cost, accessible tool to help people in recovery stay on track and reduce relapse risk.
- What could go wrong
- This is a small, early-phase trial with only 55 participants, so results may not apply broadly. The chatbot is not a substitute for medical care and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIATE SUBSTITUTION TREATMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.